3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
5
Other hematologic neoplasm
4
CNS
4
Tumor-Agnostic
3
Lymphoid
3
Genitourinary
3
Gastrointestinal
3
Sarcoma
2
Plasma cell
2
Head & Neck
2
Gynecologic
2
Dermatologic
2
Thoracic
1
Other solid neoplasm
1
NET
1
Myeloid
1
Endocrine
1
Classical hematology
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Interventions
Cisplatin
81
Gemcitabine
58
Carboplatin
57
Irinotecan
56
Paclitaxel
53
Pemetrexed
47
Docetaxel
39
Nivolumab
33
Fluorouracil
30
Bevacizumab
27
pembrolizumab
25
Cyclophosphamide
24
Capecitabine
24
Oxaliplatin
22
Leucovorin
21
Topotecan
19
durvalumab
17
Erlotinib Hydrochloride
17
Sorafenib
16
Everolimus
16
Etoposide
16
Bortezomib
16
Ipilimumab
15
Injections
15
Sunitinib
14
Filgrastim
14
Early Intervention, Educational
14
atezolizumab
13
alvocidib
13
Sirolimus
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Quality of Life
×
Other solid neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled